Derek J. Abbott

Cytokine-Neuroantigen Fusion Proteins as a New Class of Tolerogenic, Therapeutic Vaccines for Treatment of Inflammatory Demyelinating Disease in Rodent Models of Multiple Sclerosis

Mark D. Mannie, Lori Blanchfield, S.M. Touhidul Islam et al. · Frontiers in Immunology · 2012 · 26 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE)

Derek J. Abbott, Lori Blanchfield, David A. Martinson et al. · BMC Immunology · 2011 · 22 citations · Full text

Life Sciences, Immunology, Neuroscience +17

A Fusion Protein Consisting of IL-16 and the Encephalitogenic Peptide of Myelin Basic Protein Constitutes an Antigen-Specific Tolerogenic Vaccine That Inhibits Experimental Autoimmune Encephalomyelitis

Mark D. Mannie, Derek J. Abbott · The Journal of Immunology · 2007 · 20 citations · Full text

Life Sciences, Immunology, Neuroscience +17

Experimental Autoimmune Encephalomyelitis in Lewis rats: IFN-β Acts As a Tolerogenic Adjuvant for Induction of Neuroantigen-Dependent Tolerance

Mark D. Mannie, Derek J. Abbott, Lori Blanchfield · The Journal of Immunology · 2009 · 18 citations · Full text

Life Sciences, Immunology, Neuroscience +17

IL-2/Neuroantigen Fusion Proteins as Antigen-Specific Tolerogens in Experimental Autoimmune Encephalomyelitis (EAE): Correlation of T Cell-Mediated Antigen Presentation and Tolerance Induction

Mark D. Mannie, Barbara A. Clayson, Elizabeth J. Buskirk et al. · The Journal of Immunology · 2007 · 17 citations · Full text

Life Sciences, Immunology, Neuroscience +17